New smart drug DAY301 takes aim at Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase study tests a new drug called DAY301 in people with advanced solid tumors (like ovarian, lung, or breast cancer) that have not responded to standard treatments. DAY301 is designed to deliver a powerful chemotherapy directly to cancer cells that carry a specific m…
Phase: PHASE1 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC